Table 1. Numbers of retrieved and vitrified oocytes stratified by age
A. Donors
Group Age Doses of gonadotropins Nº oocyte retrieval Nº of oocyte MII Nº of oocyte GVBD Nº of oocyte GV Nº of atretic oocyte
DONOR <21 96 2087±369 17.53±8.95 14.18±7.68 0.84±1.11 1.97±2.74 0.50±0.79
21-25 121 2062±369 19.60±13.10 15.80±10.77 0.83±1.22 2.24±3.29 0.50±0.85
26-30 71 2056±434 19.75±12.70 15.13±9.74 0.83±1.11 2.85±3.37 1.00±2.74
B. Patients
Group Age Doses of gonadotropins Nº oocyte retrieval Nº of oocyte MII Nº of oocyte GVBD Nº of oocyte GV Nº of atretic oocyte
PATIENT <21 2 2025±250 12.00±7.07 8.00±.24 1.50±0.71 2.00±1.41 0.50±0.71
21-25 15 2133±342 17.80±11.92 13.60±8.96 0.93±1.10 2.80±4.74 0.47±0.74
26-30 19 2300±156 12.79±7.26a 10.89±6.91 0.84±1.07 0.79±.92a 0.26±0.45
31-35 60 2371±558 9.60±7.54a 7.43±6.05a 0.50±0.89 1.33±2.12a 0.23±0.62
36-40 192 2285±841 5.63±5.92a,b,c 4.54±4.91a,b,c 0.36±0.70 0.53±1.04a,c 0.17±0.44
41-45 100 2066±807 3.46±3.72a,b,c 2.79±3.15a,b,c 0.18±0.48a,b 0.23±0.57a,c 0.20±0.68
>45 10 1800±252 1.30±1.25a,b,c 1.20±1.32a,b,c 0.00a 0.00a 0.10±0.32
Oocytes vitrified at the MII stage. MII= metaphase II; GVBD= germinal vesicle breakdown; GV= germinal vesicle. The statistical analysis was performed and should be interpreted as follows: (a) statistically different means of the following agegroups 21 - 25 (p<0.05); (b) with 26 - 30 (p<0.05) and (c) with 31 - 35 (p<0.05).